| Uric acid and cardiovascular risk DI Feig, DH Kang, RJ Johnson New England journal of medicine 359 (17), 1811-1821, 2008 | 3083 | 2008 |
| Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? RJ Johnson, DH Kang, D Feig, S Kivlighn, J Kanellis, S Watanabe, ... hypertension 41 (6), 1183-1190, 2003 | 2268 | 2003 |
| A causal role for uric acid in fructose-induced metabolic syndrome T Nakagawa, H Hu, S Zharikov, KR Tuttle, RA Short, O Glushakova, ... American Journal of Physiology-Renal Physiology 290 (3), F625-F631, 2006 | 1593 | 2006 |
| Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease RJ Johnson, MS Segal, Y Sautin, T Nakagawa, DI Feig, DH Kang, ... The American journal of clinical nutrition 86 (4), 899-906, 2007 | 1423 | 2007 |
| Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial DI Feig, B Soletsky, RJ Johnson Jama 300 (8), 924-932, 2008 | 1243 | 2008 |
| Reactive oxygen species in tumorigenesis DI Feig, TM Reid, LA Loeb Cancer research 54 (7_Supplement), 1890s-1894s, 1994 | 796 | 1994 |
| Hyperuricemia in childhood primary hypertension DI Feig, RJ Johnson hypertension 42 (3), 247-252, 2003 | 773 | 2003 |
| Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? RJ Johnson, SE Perez-Pozo, YY Sautin, J Manitius, LG Sanchez-Lozada, ... Endocrine reviews 30 (1), 96-116, 2009 | 712 | 2009 |
| Added sugars and cardiovascular disease risk in children: a scientific statement from the American Heart Association MB Vos, JL Kaar, JA Welsh, LV Van Horn, DI Feig, CAM Anderson, ... Circulation 135 (19), e1017-e1034, 2017 | 661 | 2017 |
| 3–5 year longitudinal follow-up of pediatric patients after acute renal failure DJ Askenazi, DI Feig, NM Graham, S Hui-Stickle, SL Goldstein Kidney international 69 (1), 184-189, 2006 | 532 | 2006 |
| Uric acid reduction rectifies prehypertension in obese adolescents B Soletsky, DI Feig Hypertension 60 (5), 1148-1156, 2012 | 397 | 2012 |
| Hypothesis: uric acid, nephron number, and the pathogenesis of essential hypertension DI Feig, T Nakagawa, SA Karumanchi, WJ Oliver, DH Kang, J Finch, ... Kidney international 66 (1), 281-287, 2004 | 373 | 2004 |
| A unifying pathway for essential hypertension RJ Johnson, B Rodriguez-Iturbe, DH Kang, DI Feig, J Herrera-Acosta American journal of hypertension 18 (3), 431-440, 2005 | 276 | 2005 |
| Reverse chemical mutagenesis: identification of the mutagenic lesions resulting from reactive oxygen species-mediated damage to DNA. DI Feig, LC Sowers, LA Loeb Proceedings of the National Academy of Sciences 91 (14), 6609-6613, 1994 | 264 | 1994 |
| Serum uric acid: a risk factor and a target for treatment? DI Feig, M Mazzali, DH Kang, T Nakagawa, K Price, J Kannelis, ... Journal of the American Society of Nephrology 17 (4_suppl_2), S69-S73, 2006 | 252 | 2006 |
| Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease T Nakagawa, DH Kang, D Feig, LG Sanchez-Lozada, TR Srinivas, ... Kidney international 69 (10), 1722-1725, 2006 | 241 | 2006 |
| Uric acid: a novel mediator and marker of risk in chronic kidney disease? DI Feig Current opinion in nephrology and hypertension 18 (6), 526-530, 2009 | 210 | 2009 |
| Uric acid and hypertension: cause or effect? M Mazzali, M Kanbay, MS Segal, M Shafiu, D Jalal, DI Feig, RJ Johnson Current rheumatology reports 12, 108-117, 2010 | 208 | 2010 |
| Serum uric acid and risk of CKD in type 2 diabetes S De Cosmo, F Viazzi, A Pacilli, C Giorda, A Ceriello, S Gentile, G Russo, ... Clinical Journal of the American Society of Nephrology 10 (11), 1921-1929, 2015 | 185 | 2015 |
| Uric acid and the origins of hypertension DI Feig, M Madero, DI Jalal, LG Sanchez-Lozada, RJ Johnson The Journal of pediatrics 162 (5), 896-902, 2013 | 164 | 2013 |
